세계의 란셋 시장 보고서(2025년)
Lancet Global Market Report 2025
상품코드 : 1810932
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 란셋 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 11.0%로 확대되어 42억 5,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 당뇨병 인구 증가, 만성질환의 유병률 상승, 노인 인구의 확대, 재택 건강에 대한 기호 증가, 감염증의 이환율 증가 등에 기인하고 있습니다. 예측 기간의 주요 동향으로는 란셋 디자인의 진보, 스마트 기능의 통합, 기술 주도형 재택 진단, 세이프티 란셋의 개발, 저침습 샘플링의 진보 등을 들 수 있습니다.

당뇨병의 유병률 증가는 앞으로 수년간 란셋 시장의 성장을 이끌 것으로 예측됩니다. 당뇨병은 인슐린의 생산과 이용에 문제가 있기 때문에 체내에서 음식을 에너지로 전환하는 방법에 영향을 미치는 만성 질환입니다. 이 당뇨병 환자 증가는 주로 인슐린 저항성과 혈당 상승의 원인이 되는 식생활의 혼란, 앉기 쉬운 행동, 비만율 증가 등의 건강에 해로운 생활습관에 기인하고 있습니다. 란셋은 안전하고 정확하게 손가락 끝을 찔러 정기적인 혈당 모니터링을 가능하게함으로써 당뇨병 관리에 중요한 역할을합니다. 이 모니터링은 효과적인 질병 관리, 포도당 변동의 조기 발견, 합병증을 피하기위한 약물 요법, 다이어트, 생활 습관의 적시 조정에 필수적입니다. 예를 들어, 2023년 11월 미국 비영리 단체인 미국 당뇨병 협회(American Diabetes Association)는 2022년 미국에서 약 2,550만 명이 당뇨병으로 진단되어 총 인구의 7.6%를 차지했다고 보고했습니다. 이와 같이, 당뇨병 유병률 증가가 란셋 시장을 전진시키고 있습니다.

란셋 시장의 주요 기업은 샘플링 정확도를 높이고 혈액 채취시 통증을 줄이는 총 경로 제어 수직 구동 기술과 같은 혁신적인 기술에 주력하고 있습니다. 이 기술은 란셋의 주사 바늘이 삽입 및 제거 시 직선 수직 경로를 이동하여 횡방향 이동을 최소화하여 조직에 대한 손상, 진동 및 불쾌감을 줄여줍니다. 그 결과, 보다 정확하고 쾌적한 채혈이 가능해집니다. 예를 들어, 2025년 7월 중국의 의료기기 회사인 SteriLance Medical(Suzhou)은 OneStep 랜싱 디바이스와 소프트 센스 란셋을 스페인에서 출시했습니다. 이 캡이 없는 숨겨진 바늘 랜싱 솔루션은 특허로 보호되는 총 경로 제어 가상 드라이브 기술을 활용하여 사용자의 안전성을 향상시키면서 실질적으로 고통 없는 채혈을 제공합니다. 이 장치는 삽입, 꼬임, 밀기, 배출 등의 단순화된 4단계 워크플로우를 특징으로 하며 기존 랜싱 펜과 비교하여 준비 작업을 약 70% 줄입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

A lancet is a small, sharp, double-edged surgical instrument typically utilized for making quick, precise incisions or punctures in the skin, most commonly employed in procedures such as blood sampling, abscess drainage, or minor surgeries. It is an essential tool in both clinical and laboratory settings because of its ease of use, sterilizability, and effectiveness in minimizing tissue damage.

The main types of lancets comprise safety lancets, push button safety lancets, pressure-activated safety lancets, side button safety lancets, and personal lancets. A safety lancet is a single-use device featuring an automatic needle retraction mechanism designed to ensure safe, hygienic, and low-pain blood sampling while reducing the risk of needlestick injuries and cross-contamination. These lancets come in various gauge sizes, including 22 gauge and below, 23 to 33 gauge, and above 33 gauge. They are utilized in applications such as glucose testing, hemoglobin testing, coagulation testing, cholesterol testing, allergy testing, neonatal testing, and others. The primary end users of these lancets include hospitals, clinics, ambulatory surgery centers, homecare settings, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The lancet market research report is one of a series of new reports from The Business Research Company that provides lancet market statistics, including the lancet industry global market size, regional shares, competitors with the lancet market share, detailed lancet market segments, market trends, and opportunities, and any further data you may need to thrive in the lancet industry. This lancet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lancet market size has grown rapidly in recent years. It will grow from $2.52 billion in 2024 to $2.80 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth during the historic period can be attributed to the increasing prevalence of diabetes, rising use of self-monitoring blood glucose, growing healthcare spending, expanding middle-class population, and the rising trend toward home diagnostics.

The lancet market size is expected to see rapid growth in the next few years. It will grow to $4.25 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to the increasing diabetic population, rising prevalence of chronic diseases, expanding geriatric population, growing preference for home healthcare, and increasing incidence of infectious diseases. Major trends during the forecast period include advancements in lancet design, integration of smart features, technology-driven home diagnostics, developments in safety lancets, and progress in minimally invasive sampling.

The increasing prevalence of diabetes is expected to drive the growth of the lancet market in the coming years. Diabetes is a chronic condition that affects how the body converts food into energy due to issues with insulin production or utilization. This rise in diabetes cases is mainly attributed to unhealthy lifestyle habits such as poor diet, sedentary behavior, and growing obesity rates, which contribute to insulin resistance and elevated blood glucose levels. Lancets play a crucial role in diabetes management by allowing regular blood glucose monitoring through safe and accurate fingertip pricking. This monitoring is essential for effective disease control, early identification of glucose fluctuations, and timely adjustments in medication, diet, or lifestyle to avoid complications. For example, in November 2023, the American Diabetes Association, a US-based non-profit, reported that in 2022, about 25.5 million people in the United States were diagnosed with diabetes, representing 7.6% of the total population-a rise compared to previous years. Thus, the growing prevalence of diabetes is propelling the lancet market forward.

Leading companies in the lancet market are focusing on innovative technologies such as total path control vertical-drive technology to enhance sampling accuracy and reduce pain during blood collection. This technology ensures that the lancet needle moves in a straight, vertical path during insertion and withdrawal, minimizing lateral movement to reduce tissue damage, vibration, and discomfort. This results in a more precise and comfortable blood sampling experience. For instance, in July 2025, SteriLance Medical (Suzhou) Inc., a China-based medical device firm, launched the OneStep lancing device and SoftSense lancets in Spain. This cap-free, hidden-needle lancing solution utilizes patent-protected total path control vertical-drive technology to offer virtually painless blood sampling while improving user safety. The device features a simplified four-step workflow-insert, twist, press, and eject-that reduces preparatory actions by approximately 70% compared to traditional lancing pens.

In August 2024, MTD S.p.A., an Italy-based medical device company, acquired the Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses of Ypsomed AG for an undisclosed sum. Through this acquisition, MTD S.p.A. aims to reinforce its global leadership in diabetes and obesity care by expanding its portfolio with advanced pen needles, lancets, and blood glucose monitoring systems. This move will boost production capacity and enable the company to enter high-growth markets like China and India while strengthening its footprint in North America and Europe. Ypsomed AG is a Switzerland-based manufacturer specializing in lancets and other self-injection devices.

Major players in the lancet market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, SARSTEDT AG & Co. KG, B. Braun Melsungen AG, Owen Mumford Limited, Amkay Products Pvt. Ltd, Quest Medical Inc., NARANG MEDICAL LIMITED, GBUK GROUP LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, Sterimed Medical Devices Private Limited, MediPoint Holdings, MediPurpose Pte. Ltd, Carelife USA Inc., Germaine Laboratories Inc., Shandong Lianfa Medical Plastic Products Co. Ltd, and Ambimed Healthcare Private Limited.

North America was the largest region in the lancet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lancet report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lancet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lancet market consists of sales of adjustable-depth lancets, pediatric lancets, blood glucose testing kits, multi-lancet devices, and heel lancets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lancet Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lancet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lancet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lancet market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Lancet Market Characteristics

3. Lancet Market Trends And Strategies

4. Lancet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lancet Growth Analysis And Strategic Analysis Framework

6. Lancet Market Segmentation

7. Lancet Market Regional And Country Analysis

8. Asia-Pacific Lancet Market

9. China Lancet Market

10. India Lancet Market

11. Japan Lancet Market

12. Australia Lancet Market

13. Indonesia Lancet Market

14. South Korea Lancet Market

15. Western Europe Lancet Market

16. UK Lancet Market

17. Germany Lancet Market

18. France Lancet Market

19. Italy Lancet Market

20. Spain Lancet Market

21. Eastern Europe Lancet Market

22. Russia Lancet Market

23. North America Lancet Market

24. USA Lancet Market

25. Canada Lancet Market

26. South America Lancet Market

27. Brazil Lancet Market

28. Middle East Lancet Market

29. Africa Lancet Market

30. Lancet Market Competitive Landscape And Company Profiles

31. Lancet Market Other Major And Innovative Companies

32. Global Lancet Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lancet Market

34. Recent Developments In The Lancet Market

35. Lancet Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기